论文部分内容阅读
2016年我国医药行业政策频出,国务院、国家卫生计生委、国家食药监总局等部门相继颁布多条政策法规。在此背景下,清科研究中心近日对外发布《2017年中国医药行业投资研究报告》(以下简称《报告》)。《报告》显示,2010-2016年中国股权投资市场医药行业大体是上升趋势,投资金额平均增长率更是高达89.0%,尤其是2015年和2016年,医药行业股权投资增加迅
In 2016, there are frequent policies in the pharmaceutical industry in our country. Several departments and policies such as the State Council, the National Health and Family Planning Commission and the State Food and Drug Administration have successively promulgated various policies and regulations. In this context, Zero2IPO Research Center recently released the “2017 China Pharmaceutical Industry Investment Research Report” (the “Report”). The Report shows that the pharmaceutical industry in the Chinese equity market in 2010-2016 is generally on the rise with an average growth rate of investment of 89.0%. In particular, in 2015 and 2016, the equity investment in the pharmaceutical industry increased rapidly